Skip to main content
    B

    BrightSpring Health Services, Inc. Common Stock (BTSG)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $71.37
    +0.16 (+0.22%)

    Market Cap: $14.17B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    BrightSpring Health Services, Inc. Common Stock (BTSG) Financials: Revenue, Profit and Cash Flow

    Updated Oct 30, 2026. Financial statements from company filings, amounts in US dollars.

    BrightSpring Health Services, Inc. Common Stock reported revenue of $12.91B for the fiscal year ended Dec 31, 2025, up 28.2% from the year before. That year, net income was $189.11M with a net margin of 1.5%, operating cash flow was $490.17M and free cash flow was $394.69M. The quarter ended Sep 30, 2026 had revenue of $4.21B and net income of $100.30M.

    Revenue and Margins

    The operating margin was 2.3% in the fiscal year ended Dec 2025. Over the 7 years to Dec 2025, revenue grew from $2.54B, a compound annual rate of 26.1%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$12.91B+28.2%11.8%2.3%1.5%
    Dec 2024$10.07B+31.0%12.6%1.1%-0.2%
    Dec 2023$7.69B-0.4%14.8%0.8%-2.0%
    Dec 2022$7.72B+15.3%17.5%2.4%-0.7%
    Dec 2021$6.70B+20.0%18.6%3.5%0.7%
    Dec 2020$5.58B+23.3%18.8%3.0%0.4%
    Dec 2019$4.53B+78.4%18.4%1.4%-1.6%
    Dec 2018$2.54BN/A14.8%3.0%-0.3%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 81.6% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$12.91B$10.07B$7.69B$7.72B$6.70B$5.58B$4.53B$2.54B
    Cost of revenue$11.39B$8.81B$6.55B$6.37B$5.45B$4.53B$3.69B$2.16B
    Gross profit$1.52B$1.27B$1.14B$1.35B$1.25B$1.05B$833.91M$375.91M
    Operating income$295.25M$107.95M$58.13M$187.83M$234.18M$165.19M$63.31M$74.85M
    Net income$189.11M-$20.52M-$156.84M-$54.22M$49.80M$20.81M-$72.38M-$7.62M
    EBITDA$470.77M$324.54M$281.38M$412.24M$433.34M$346.69M$218.18M$156.02M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$4.21B$3.87B$3.61B$3.55B$3.33B$3.15B$2.88B$2.75B$2.60B$2.44B$2.29B$1.24B
    Gross profit$518.55M$492.75M$482.22M$412.55M$392.01M$374.85M$338.37M$338.67M$323.09M$312.18M$292.49M$73.92M
    Operating income$160.48M$130.39M$121.45M$108.11M$87.84M$48.56M$50.74M$55.54M$29.10M$38.65M-$15.34M-$20.79M
    Net income$100.30M$84.21M$148.61M$77.32M$55.24M$27.54M$29.01M$15.40M-$8.98M$19.44M-$46.38M-$7.20M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.51B exceeded cash and equivalents by $2.42B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$6.41B$5.93B$5.53B$5.44B$5.51B$4.54B$3.82BN/A
    Current assets$2.89B$1.89B$1.46B$1.34B$1.18B$1.29B$870.68MN/A
    Cash and equivalents$88.37M$60.95M$13.07M$13.63M$46.73M$262.00M$18.30MN/A
    Total liabilities$4.53B$4.27B$4.92B$4.66B$4.71B$3.81B$3.11BN/A
    Short-term debt$52.34M$48.73M$32.27M$107.86M$125.22M$91.01M$89.50MN/A
    Long-term debt$2.46B$2.56B$3.33B$3.36B$3.39B$2.67BN/AN/A
    Shareholder equity$1.88B$1.65B$584.74M$754.78M$774.82M$704.98M$656.87MN/A
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$6.27B$5.99B$6.21B$6.41B$6.05B$5.94B$5.85B$5.93B$5.79B$5.61B$5.66B$5.53B
    Total liabilities$4.08B$3.93B$4.22B$4.53B$4.23B$4.20B$4.16B$4.27B$4.17B$4.00B$4.08B$4.92B
    Cash and equivalents$717.84M$550.38M$888.80M$88.37M$140.34M$70.07M$52.34M$61.25M$35.97M$25.03M$58.04M$13.07M
    Shareholder equity$2.18B$2.05B$1.98B$1.88B$1.82B$1.74B$1.69B$1.65B$1.61B$1.60B$1.57B$584.74M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 80.5% of operating cash flow. Share repurchases came to 12.2% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$490.17M$23.77M$210.78M-$4.65M$270.17M$222.64M$110.91M$76.45M
    Capital expenditures$95.48M$80.91M$73.53M$70.11M$59.27M$51.91M$51.22M$33.20M
    Free cash flow$394.69M-$57.14M$137.26M-$74.77M$210.90M$170.73M$59.69M$43.25M
    Dividends paidN/AN/AN/A$750.00KN/AN/AN/AN/A
    Share repurchases$48.27M$2.97M$650.00K$0N/AN/AN/AN/A
    Investing cash flow-$305.08M-$140.24M-$134.43M$45.36M-$1.19B-$452.87M-$1.53B-$37.34M
    Financing cash flow-$157.87M$164.65M-$76.91M-$73.81M$705.22M$473.94M$1.41B-$32.21M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$204.32M$43.92M$122.94M$231.56M$107.94M$49.08M$101.60M$90.61M$27.25M-$15.22M-$78.86M$162.40M
    Capital expenditures$22.09M$29.03M$21.54M$37.66M$15.76M$24.43M$17.63M$15.31M$20.04M$23.74M$21.82M$16.83M
    Free cash flow$182.23M$14.88M$101.40M$193.89M$92.17M$24.65M$83.97M$75.30M$7.20M-$38.97M-$100.67M$145.57M
    Last 12 quarters

    Frequently Asked Questions About BTSG

    What is BrightSpring Health Services, Inc. Common Stock's annual revenue?

    BrightSpring Health Services, Inc. Common Stock reported revenue of $12.91B for the fiscal year ended Dec 31, 2025.

    How fast is BrightSpring Health Services, Inc. Common Stock's revenue growing?

    Revenue was up 28.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.7%.

    Is BrightSpring Health Services, Inc. Common Stock profitable?

    Yes. BrightSpring Health Services, Inc. Common Stock reported net income of $189.11M for the fiscal year ended Dec 31, 2025, with a net margin of 1.5%.

    How much free cash flow does BTSG generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $490.17M minus capital expenditures of $95.48M produced free cash flow of $394.69M.

    How much debt does BrightSpring Health Services, Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $2.46B, short-term debt of $52.34M and cash and equivalents of $88.37M.